These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent. Soliani P, Ziegler S, Romani A, Corcione L, Campanini N, Dell'Abate P, Del Rio P, Sianesi M. Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555 [Abstract] [Full Text] [Related]
3. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. Sawan A, Lascu I, Veron M, Anderson JJ, Wright C, Horne CH, Angus B. J Pathol; 1994 Jan; 172(1):27-34. PubMed ID: 7931824 [Abstract] [Full Text] [Related]
4. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A. J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051 [Abstract] [Full Text] [Related]
5. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver. Lamb RF, Going JJ, Pickford I, Birnie GD. Cancer Res; 1996 Feb 15; 56(4):916-20. PubMed ID: 8631033 [Abstract] [Full Text] [Related]
6. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. Sarris M, Lee CS. Eur J Surg Oncol; 2001 Mar 15; 27(2):170-4. PubMed ID: 11289754 [Abstract] [Full Text] [Related]
7. [The role of nm23 protein in progression of sporadic adenocarcinoma of the large intestine]. Paluszkiewicz P, Pawłowska-Wakowicz B, Karski J. Wiad Lek; 1997 Mar 15; 50 Suppl 1 Pt 1():82-6. PubMed ID: 9446409 [Abstract] [Full Text] [Related]
8. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer. Giarnieri E, Alderisio M, Valli C, Vecchione A, Forte A, Turano R, Pulcini M. Anticancer Res; 1995 Mar 15; 15(5B):2049-53. PubMed ID: 8572601 [Abstract] [Full Text] [Related]
9. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays. Charpin C, Garcia S, Bonnier P, Martini F, Andrac L, Horschowski N, Lavaut MN, Allasia C. J Pathol; 1998 Apr 15; 184(4):401-7. PubMed ID: 9664906 [Abstract] [Full Text] [Related]
10. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S. Croat Med J; 2003 Aug 15; 44(4):429-34. PubMed ID: 12950146 [Abstract] [Full Text] [Related]
11. Differential expression of the nm23 protein in the progression of oesophageal adenocarcinoma. Sarris M, Konopka M, Lee CS. Pathology; 2003 Feb 15; 35(1):37-41. PubMed ID: 12701682 [Abstract] [Full Text] [Related]
12. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer]. Fan YZ, Li XP, Liu WF, Li GM. Zhonghua Wai Ke Za Zhi; 2006 Feb 01; 44(3):181-5. PubMed ID: 16635348 [Abstract] [Full Text] [Related]
13. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma. Schneider J, Pollán M, Jiménez E, Marenbach K, Martínez N, Volm M, Marx D, Meden H. Br J Cancer; 2000 May 01; 82(10):1662-70. PubMed ID: 10817501 [Abstract] [Full Text] [Related]
14. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Gynecol Oncol; 1996 Mar 01; 60(3):363-72. PubMed ID: 8774640 [Abstract] [Full Text] [Related]
15. Overexpression of nm23-H4 RNA in colorectal and renal tumours. Hayer J, Engel M, Seifert M, Seitz G, Welter C. Anticancer Res; 2001 Mar 01; 21(4A):2821-5. PubMed ID: 11724361 [Abstract] [Full Text] [Related]
16. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer. Brenner AS, Thebo JS, Senagore AJ, Duepree HJ, Gramlich T, Ormsby A, Lavery IC, Fazio VW. Am Surg; 2003 Mar 01; 69(3):203-8; discussion 208. PubMed ID: 12678475 [Abstract] [Full Text] [Related]
17. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression. Berney CR, Yang J, Fisher RJ, Russell PJ, Crowe PJ. Oncol Res; 1998 Mar 01; 10(1):47-54. PubMed ID: 9613457 [Abstract] [Full Text] [Related]
18. [Immunohistochemical analysis of nm23 gene product/nucleoside-diphosphate kinase expression in human lung carcinoma]. Jiang Y, He A, Xia S. Zhonghua Jie He He Hu Xi Za Zhi; 1995 Aug 01; 18(4):209-11, 254. PubMed ID: 8697510 [Abstract] [Full Text] [Related]
19. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma. Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC. Gynecol Oncol; 1997 Aug 01; 66(2):238-45. PubMed ID: 9264569 [Abstract] [Full Text] [Related]
20. nm23 expression in advanced and borderline ovarian carcinoma. Schneider J, Romero H, Ruiz R, Centeno MM, Rodriguez-Escudero FJ. Anticancer Res; 1996 Aug 01; 16(3A):1197-202. PubMed ID: 8702236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]